Citation 101145

TANAKA,T: TSUKUDA,E: UOSAKI,Y: MATSUDA,Y:. (1996). EI-1511-3, -5 AND EI-1625-2, NOVEL INTERLEUKIN-1-BETA CONVERTING ENZYME INHIBITORS PRODUCED BY STREPTOMYCES SP. E-1511 AND E-1625. III. BIOCHEMICAL PROPERTIES OF EI-1511-3, -5 AND EI-1625-2.. 49(11)

Citation Details

TitleEI-1511-3, -5 AND EI-1625-2, NOVEL INTERLEUKIN-1-BETA CONVERTING ENZYME INHIBITORS PRODUCED BY STREPTOMYCES SP. E-1511 AND E-1625. III. BIOCHEMICAL PROPERTIES OF EI-1511-3, -5 AND EI-1625-2.
AuthorsTANAKA,T: TSUKUDA,E: UOSAKI,Y: MATSUDA,Y:
Year1996
Volume49
Issue11

Summary

Year: 1996

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #Pharmacology TypeWorktypesCompoundResults
1
CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
STREPTOMYCES ANTIBIOTIC EI-1511-3
ACTIVE
2
ELASTASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
STREPTOMYCES ANTIBIOTIC EI-1511-3
INACTIVE
3
CATHEPSIN B INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
STREPTOMYCES ANTIBIOTIC EI-1511-3
INACTIVE
4
INTERLEUKIN-1-BETA RELEASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
STREPTOMYCES ANTIBIOTIC EI-1511-3
ACTIVE
5
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
STREPTOMYCES ANTIBIOTIC EI-1511-3
INACTIVE
6
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
STREPTOMYCES ANTIBIOTIC EI-1511-3
WEAK ACTIVITY
7
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
STREPTOMYCES ANTIBIOTIC EI-1511-3
WEAK ACTIVITY
8
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
STREPTOMYCES ANTIBIOTIC EI-1511-3
WEAK ACTIVITY
9
INTERLEUKIN-1-BETA CONVERTING ENZYME INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
STREPTOMYCES ANTIBIOTIC EI-1511-5
ACTIVE
10
ELASTASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
STREPTOMYCES ANTIBIOTIC EI-1511-5
INACTIVE
11
CATHEPSIN B INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
STREPTOMYCES ANTIBIOTIC EI-1511-5
INACTIVE
12
INTERLEUKIN-1-BETA RELEASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
STREPTOMYCES ANTIBIOTIC EI-1511-5
ACTIVE
13
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
STREPTOMYCES ANTIBIOTIC EI-1511-5
WEAK ACTIVITY
14
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
STREPTOMYCES ANTIBIOTIC EI-1511-5
WEAK ACTIVITY
15
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
STREPTOMYCES ANTIBIOTIC EI-1511-5
WEAK ACTIVITY
16
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
STREPTOMYCES ANTIBIOTIC EI-1511-5
WEAK ACTIVITY
17
INTERLEUKIN-1-BETA CONVERTING ENZYME INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
STREPTOMYCES ANTIBIOTIC EI-1625-2
ACTIVE
18
ELASTASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
STREPTOMYCES ANTIBIOTIC EI-1625-2
INACTIVE
19
CATHEPSIN B INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
STREPTOMYCES ANTIBIOTIC EI-1625-2
INACTIVE
20
INTERLEUKIN-1-BETA RELEASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
STREPTOMYCES ANTIBIOTIC EI-1625-2
ACTIVE
21
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
STREPTOMYCES ANTIBIOTIC EI-1625-2
INACTIVE
22
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
STREPTOMYCES ANTIBIOTIC EI-1625-2
WEAK ACTIVITY
23
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
STREPTOMYCES ANTIBIOTIC EI-1625-2
WEAK ACTIVITY
24
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
STREPTOMYCES ANTIBIOTIC EI-1625-2
WEAK ACTIVITY
Show SPARQL Queries (1)